The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, producing billions in income, its exclusivity period created a wave of knock-off https://pr6bookmark.com/story21600785/copyright-s-pill-and-big-pharma-a-risky-venture